Work

In vitro Potential Antiviral SARS-CoV-2 activity of Thymoquinone, the main Nigella sativa component

Year: 2025

Type: article

Source: Research Journal of Pharmacy and Technology

DOI: 10.52711/0974-360x.2025.00251

Authors: Rhazzar Zineb, Regragui Rim, Touil Nadia, El Fahime Elmostafa, Oukessou Mohamed, Fellahi Siham, Nyabi Omar, Gala Jean-Luc, Ennibi Khalid

Institutions: Institut Agronomique et Vétérinaire Hassan II, Mohammed V University, UCLouvain

Language: English

Topic: Nigella sativa pharmacological applications

Subfield: Complementary and alternative medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410211579

FWCI: 1.03

Cites: 39

Cited by: 1

Related to: 10